MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
According to ChainCatcher, strategic transformation information jointly led by Titan Partners Group and crypto investment firm GSR indicates that U.S. pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing its dedicated Litecoin treasury strategy. More than $100 million in funding commitments have already been made to the project.
Notably, Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors. In addition, the Litecoin Foundation has invested in MEI Pharma, as the company’s treasury strategy closely aligns with the Foundation’s core mission of promoting global Litecoin adoption.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jefferson: The current policy stance is conducive to adjusting the magnitude and timing of interest rate changes
Jefferson: Inflation is expected to return to the 2% path, but upside risks remain
Bowman: Underlying inflation is close to the Federal Reserve's 2% target
Bowman: The Federal Reserve should not signal a pause in rate cuts
Trending news
MoreCrypto prices
More
